Global Nuclear Medicine Market By Overview
Radioactive materials and isotopes used for diagnosis and treatment of diseases such as cancers, neurological disorders, gastrointestinal, heart disease, etc. are known as nuclear medicines. Nuclear medicines help in the identification of diseases at an early stage by observing the molecular activity of cells within the body. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine .The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period.
Global Nuclear Medicine Market By Dynamics
Increasing number of cancer cases
The nuclear medicine market is currently in its growth stage driven by an increasing number of cancer cases and rising awareness about nuclear medicine. Increasing incidences of cancer and cardiac ailments are the major drivers for the target market growth. Nuclear medicine shows a huge potential in treating cardiac and cancer diseases. Several factors are poised to augment the demand for nuclear medicine, but none bigger than the growing prevalence of cancer and cardiac disorders. Advances in radiotracers, the advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments, and investments via public and private partnerships to revolutionize diagnostic measures are some of the other factors expected to drive the demand for the target market shortly.
However, major factors hampering the growth of the global nuclear medicine market are the high cost of diagnostic equipment and the high cost of treatment. Also, stringent government regulations for drug approval and drug usage are other factors hampering the growth of the target market. However, increasing the application of nuclear medicine in neurological applications is expected to create lucrative opportunities for major manufacturers in the global market over the forecast period.
Global Nuclear Medicine Market By Segmentation
The nuclear medicine market is segmented by diagnostics, by therapeutics, by applications, and by regions.
Based on diagnostics, the global nuclear medicine market is segmented into Single Photon Emission, Computed Tomography (SPECT), and Positron Emission Tomography (PET). Based on the Therapeutics the target market is segmented into Alpha Emitters, Beta Emitters, and Brachytherapy. Based on the application, the target market is bifurcated into Cardiology, Neurology, Oncology, and Other Applications.
Regional Insights:
For detailed understanding of market dynamics, based on the region the global nuclear medicine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global nuclear medicine market due to the growing demand for advanced medical technologies and the increasing geriatric population. Asia Pacific Nuclear Medicine market is projected to register a high CAGR over the forecast period owing to the growing trend of medical tourism, rising healthcare awareness, coupled with a continuous and growing demand for advanced medical technologies.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Diagnostic- Single Photon Emission, Computed Tomography (SPECT), and Positron Emission Tomography (PET) By Therapeutics- Alpha Emitters, Beta Emitters, and Brachytherapy By Application- Cardiology, Neurology, Oncology, and Other Applications |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Nuclear Medicine Market, By Diagnostics:
- Single Photon Emission
- Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
Global Nuclear Medicine Market, By Therapeutics:
- Alpha Emitters
- Beta Emitters
- Brachytherapy
Global Nuclear Medicine Market, By Application:
- Cardiology
- Neurology
- Oncology
- Other applications
Global Nuclear Medicine Market, By Region:
-
-
- North America
- North America Nuclear Medicine Market, By Diagnostics
- North America Nuclear Medicine Market, By Therapeutics
- North America Nuclear Medicine Market, By Application
- North America Nuclear Medicine Market, By Country
- The U.S.
- Canada
- Europe
- Europe Nuclear Medicine Market, By Product
- Europe Nuclear Medicine Market, By Therapeutics
- Europe Nuclear Medicine Market, By Application
- Europe Nuclear Medicine Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Nuclear Medicine Market, By Product
- Asia Pacific Nuclear Medicine Market, By Therapeutics
- Asia Pacific Nuclear Medicine Market, By Application
- Asia Pacific Nuclear Medicine Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Nuclear Medicine Market, By Product
- Latin America Nuclear Medicine Market, By Therapeutics
- Latin America Nuclear Medicine Market, By Application
- Latin America Nuclear Medicine Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Nuclear Medicine Market, By Product
- Middle East & Africa Nuclear Medicine Market, By Therapeutics
- Middle East & Africa Nuclear Medicine Market, By Application
- Middle East & Africa Nuclear Medicine Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
-
Global Nuclear Medicine Market By Key Players
The key players operating the global nuclear medicine market involves Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A, Nordion, Inc., The Institute of Radioelements, Australian Nuclear Science & Technology Organization (ANSTO), NTP Radioisotopes SOC Ltd., and Eczacibasi-Monroe
Global Nuclear Medicine Market By Company Profile
- Eckert & Ziegler Group
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Mallinckrodt Pharmaceuticals
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- GE Healthcare; Jubilant Life Sciences
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Bracco Imaging S.p.A
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Nordion, Inc.
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- The Institute of Radioelements
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Australian Nuclear Science & Technology Organization
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- NTP Radioisotopes SOC Ltd
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Eczacibasi-Monrol
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Curium
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
Global Nuclear Medicine Market By Table of Contents
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Nuclear Medicine Strategies
- Key Questions this Study will Answer
- Market Snippet, By Diagnostics
- Market Snippet, By Therapeutics
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Nuclear Medicine Market, By Diagnostics , 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Single Photon Emission
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Computed Tomography (SPECT)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Positron Emission Tomography (PET)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Nuclear Medicine Market, By Therapeutics, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Alpha Emitters
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Beta Emitters
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Brachytherapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Nuclear Medicine Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cardiology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Neurology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Other applications
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Nuclear Medicine Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Diagnostics s, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Therapeutics , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Oncology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Diagnostics s, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Therapeutics , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Oncology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Diagnostics s, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Therapeutics , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Oncology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Diagnostics s, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Therapeutics , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Oncology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Diagnostics s, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Therapeutics , 2020 – 2030
- Market Size and Forecast (US$ Mn), By Oncology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Eckert & Ziegler Group
- Company Overview
-
-
-
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
-
-
- Mallinckrodt Pharmaceuticals
- GE Healthcare; Jubilant Life Sciences
- Bracco Imaging S.p.A
- Nordion, Inc.
- The Institute of Radioelements
- Australian Nuclear Science & Technology Organization
- NTP Radioisotopes SOC Ltd
- Eczacibasi-Monrol
- Curium
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The nuclear medicine market is segmented by diagnostics, by therapeutics, by applications, and by regions.
The nuclear medicine market is currently in its growth stage driven by an increasing number of cancer cases and rising awareness about nuclear medicine.
The market in North America accounts highest revenue share to the global nuclear medicine market due to the growing demand for advanced medical technologies and the increasing geriatric population.
The key players operating the global nuclear medicine market involves Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A, Nordion, Inc., The Institute of Radioelements, Australian Nuclear Science & Technology Organization (ANSTO), NTP Radioisotopes SOC Ltd., and Eczacibasi-Monroe.